Literature DB >> 33905603

Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing).

.   

Abstract

Entities:  

Keywords:  consensus; diagnosis; inflammatory bowel diseases; treatment

Year:  2021        PMID： 33905603     DOI： 10.1111/1751-2980.12994

Source DB:  PubMed          Journal:  J Dig Dis        ISSN： 1751-2972            Impact factor:   2.325


× No keyword cloud information.
  10 in total

1.  Prevalence and factors associated with fatigue in patients with ulcerative colitis in China: a cross-sectional study.

Authors:  Feng Xu; Jingyi Hu; Qian Yang; Yuejin Ji; Cheng Cheng; Lei Zhu; Hong Shen
Journal:  BMC Gastroenterol       Date:  2022-06-03       Impact factor: 2.847

2.  Venlafaxine as an Adjuvant Therapy for Inflammatory Bowel Disease Patients With Anxious and Depressive Symptoms: A Randomized Controlled Trial.

Authors:  Chang Liang; Pingrun Chen; Yu Tang; Chuheng Zhang; Na Lei; Ying Luo; Shihao Duan; Yan Zhang
Journal:  Front Psychiatry       Date:  2022-05-19       Impact factor: 5.435

3.  Mucosa-Colonizing Microbiota Correlate With Host Autophagy Signaling in Patients With Inflammatory Bowel Disease.

Authors:  Wenxue Wang; Zhongjian Liu; Wei Yue; Ling Zhu; Huijie Zhong; Chao Yang; Tian He; Ping Wan; Jiawei Geng
Journal:  Front Microbiol       Date:  2022-05-26       Impact factor: 6.064

4.  Artificial Neural Network Analysis-Based Immune-Related Signatures of Primary Non-Response to Infliximab in Patients With Ulcerative Colitis.

Authors:  Xuanfu Chen; Lingjuan Jiang; Wei Han; Xiaoyin Bai; Gechong Ruan; Mingyue Guo; Runing Zhou; Haozheng Liang; Hong Yang; Jiaming Qian
Journal:  Front Immunol       Date:  2021-12-21       Impact factor: 7.561

5.  Potential role of MALT1 as a candidate biomarker of disease surveillance and treatment response prediction in inflammatory bowel disease patients.

Authors:  Zhigang Wu; Yingyan Bi
Journal:  J Clin Lab Anal       Date:  2022-01-08       Impact factor: 2.352

6.  Exclusive enteral nutrition remodels the intestinal flora in patients with active Crohn's disease.

Authors:  Jingjing Jiang; Lu Chen; Yanfang Chen; Hong Chen
Journal:  BMC Gastroenterol       Date:  2022-04-30       Impact factor: 3.067

7.  Drug hypersensitivity syndrome induced by sulfasalazine: A case report.

Authors:  Dong-Hui Chen; Hai-Rong Zhou; Yong-Gang Zhang; Guan-Yuan Shen; Chong Xu; Chun-Li Guan
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

8.  Sex-specific comparison of clinical characteristics and prognosis in Crohn's disease: A retrospective cohort study of 611 patients in China.

Authors:  Zhaoshi Liu; Xiaoyin Bai; Huimin Zhang; Zheng Wang; Hong Yang; Jiaming Qian
Journal:  Front Physiol       Date:  2022-09-29       Impact factor: 4.755

9.  Research hotspot and trend analysis in the diagnosis of inflammatory bowel disease: A machine learning bibliometric analysis from 2012 to 2021.

Authors:  Chuan Liu; Rong Yu; Jixiang Zhang; Shuchun Wei; Fumin Xue; Yingyun Guo; Pengzhan He; Lining Shang; Weiguo Dong
Journal:  Front Immunol       Date:  2022-09-14       Impact factor: 8.786

10.  Significance of diagnosis and prognosis for appendiceal orifice inflammation in ulcerative colitis: a real-world study.

Authors:  Peng Deng; Peng Yao; Chao Pei; Xiao Li; Junchao Wu; Shu Zhang
Journal:  BMJ Open       Date:  2022-09-30       Impact factor: 3.006
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.